Actively Recruiting
Status Epilepticus Population Study (STEPS)
Led by University Hospital, Basel, Switzerland · Updated on 2025-02-14
1000
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an observational multicenter cohort study to better understand how adapting treatment based on outcome prediction models, risk assessment, and monitoring affects adults with status epilepticus (SE). The study aims to explore treatment effects, complication detection, prevention, and management on the course and outcomes of SE in adult patients. The study involves collecting patient data from digital medical records and electroencephalographic and microbiologic databases. It includes adult patients diagnosed with SE who were treated at specific hospitals between 2005 and 2023. The collected data cover prehospital emergency care, seizure details, ICU and hospital stays, clinical scores, laboratory parameters, and vital signs. Participants' involvement includes data extraction from existing records and databases related to their SE episodes. Researchers will analyze demographic information, seizure history and characteristics, treatment details, clinical monitoring scores, laboratory results, and outcomes. The study spans data collected over nearly two decades, focusing on a comprehensive understanding of SE management and patient outcomes.
CONDITIONS
Brief Title
Status Epilepticus Population Study (STEPS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years of age or older
- Diagnosed with status epilepticus between 2005 and 2023
- Treated at University Hospital of Basel or Cantonal Hospital Aarau
You will not qualify if you...
- Patients younger than 18 years
- Patients with repetitive epileptic seizures not qualifying as status epilepticus
- Patients with documented refusal of the general consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) to confirm eligibility based on medical history
Duration - Data collected retrospectively from 2005 to 2023
Participants who underwent routine care for status epilepticus are observed through extraction of their medical, EEG, and microbiologic data.
No additional visits; data are collected from existing medical records
Trial Site Locations
Total: 2 locations
1
Cantonal Hospital Aarau (KSA)
Aarau, Switzerland, 5001
Actively Recruiting
2
Clinic for Intensive Care Medicine, University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
R
Raoul Sutter, PD Dr. med
S
Saskia Semmlack, Dr. med
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here